Robert Clark
Director/Board Member presso INCANNEX HEALTHCARE INC.
Patrimonio netto: 359 000 $ in data 31/03/2024
Profilo
Robert Bruce Clark currently works at Incannex Healthcare, Inc., as Independent Non-Executive Director from 2022 and Novo Nordisk, Inc., as Vice President-Regulatory Affairs from 2012.
Mr. Clark also formerly worked at Pfizer Inc., as Head-United States Regulatory Strategy from 1992 to 2021.
Mr. Clark received his graduate degree from New York Medical College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
INCANNEX HEALTHCARE INC.
0.63% | 21/12/2023 | 100 000 ( 0.63% ) | 359 000 $ | 31/03/2024 |
Posizioni attive di Robert Clark
| Società | Posizione | Inizio |
|---|---|---|
| INCANNEX HEALTHCARE INC. | Director/Board Member | 17/08/2022 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | General Counsel | 01/01/2012 |
Precedenti posizioni note di Robert Clark
| Società | Posizione | Fine |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2021 |
Formazione di Robert Clark
| New York Medical College | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| INCANNEX HEALTHCARE INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
- Borsa valori
- Insiders
- Robert Clark
